We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Stock Moves -4.15%: What You Should Know
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed at $19.19 in the latest trading session, marking a -4.15% move from the prior day. Elsewhere, the Dow saw a downswing of 0.25%, while the tech-heavy Nasdaq appreciated by 0.31%.
The company's shares have seen an increase of 33.38% over the last month, surpassing the Finance sector's gain of 3.26% and the S&P 500's gain of 5.05%.
The investment community will be closely monitoring the performance of Oscar Health, Inc. in its forthcoming earnings report. The company is expected to report EPS of $0.34, up 70% from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $2.86 billion, showing a 28.96% escalation compared to the year-ago quarter.
OSCR's full-year Zacks Consensus Estimates are calling for earnings of $0.61 per share and revenue of $11.21 billion. These results would represent year-over-year changes of +510% and +22.12%, respectively.
Investors should also note any recent changes to analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, there's been a 11.11% fall in the Zacks Consensus EPS estimate. Oscar Health, Inc. is holding a Zacks Rank of #3 (Hold) right now.
Looking at valuation, Oscar Health, Inc. is presently trading at a Forward P/E ratio of 32.64. Its industry sports an average Forward P/E of 9.92, so one might conclude that Oscar Health, Inc. is trading at a premium comparatively.
The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 70, placing it within the top 29% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Oscar Health, Inc. (OSCR) Stock Moves -4.15%: What You Should Know
Oscar Health, Inc. (OSCR - Free Report) closed at $19.19 in the latest trading session, marking a -4.15% move from the prior day. Elsewhere, the Dow saw a downswing of 0.25%, while the tech-heavy Nasdaq appreciated by 0.31%.
The company's shares have seen an increase of 33.38% over the last month, surpassing the Finance sector's gain of 3.26% and the S&P 500's gain of 5.05%.
The investment community will be closely monitoring the performance of Oscar Health, Inc. in its forthcoming earnings report. The company is expected to report EPS of $0.34, up 70% from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $2.86 billion, showing a 28.96% escalation compared to the year-ago quarter.
OSCR's full-year Zacks Consensus Estimates are calling for earnings of $0.61 per share and revenue of $11.21 billion. These results would represent year-over-year changes of +510% and +22.12%, respectively.
Investors should also note any recent changes to analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, there's been a 11.11% fall in the Zacks Consensus EPS estimate. Oscar Health, Inc. is holding a Zacks Rank of #3 (Hold) right now.
Looking at valuation, Oscar Health, Inc. is presently trading at a Forward P/E ratio of 32.64. Its industry sports an average Forward P/E of 9.92, so one might conclude that Oscar Health, Inc. is trading at a premium comparatively.
The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 70, placing it within the top 29% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.